Managing Director
Cirix Inc.
AeroLeads people directory · profile
Sean Mcbride Email & Phone Number
Managing Director
at
Life Sciences Ontario
1 work email found
@bayshore.ca
1 phone found area 902
LinkedIn matched
✓ Verified Jul 2026
4 data sources
Profile completeness 100%
Who is Sean Mcbride? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Sean Mcbride is listed as Managing Director at Life Sciences Ontario, based in Oakville, Ontario, Canada. AeroLeads shows a work email signal at bayshore.ca, phone signal with area code 902, and a matched LinkedIn profile for Sean Mcbride.
Sean Mcbride previously worked as Managing Director at Cirix Inc. and Principal at Cirix Inc.. Sean Mcbride holds Bba, Major: Marketing, Finance Minor: Economics from Simon Fraser University.
Company email context
Email format at Life Sciences Ontario
This section adds company-level context without repeating Sean Mcbride's masked contact details.
{first_initial}{last}@bayshore.ca
86% confidence
AeroLeads found 1 current-domain work email signal for Sean Mcbride. Compare company email patterns before reaching out.
Profile bio
About Sean Mcbride
Solution and results oriented healthcare executive with achievements focused on creating sustainable patient access, developing strategy for complex business challenges & creating leading brands. Effective team builder and coach, leading direct & cross functional teams to success in strategic commercial (marketing, business development, sales), market access & reimbursement. Experience leading new product launches, market assessments, access/ reimbursement & resource planning. Skilled at engaging local & global teams, fostering stakeholder partnerships, alliance partners, B2B, government & policy groups with broad therapeutic experience including rare disease, oncology, hematology, immuno/vaccines & medical devices. Strategic agility & business planning to lead others with a can-do attitude. Experience managing market channels including payers, PBM, hospital/IDN's, wholesaler/trade, retail & specialty pharmacy. Skilled negotiator with BD deal sheet of successful licensing, purchase agreements & contracts. Solid financial acumen experienced with P&L, resource allocation, budget & forecasting. Key Accomplishments:• Led cross functional marketing/sales, market access/reimbursement strategy, for business performance turnaround of $170+M hospital/specialty business.• Led launch & reimbursement strategy for US & EU markets including development of value dossier.• Negotiated PLA increasing revenue ($15M+) with success of model adapted to companies largest brand.• Led sales, marketing & cross functional life cycle team to launch 5 biologics in 3 yrs• Developed strategies to become market leader with >90% share in a price sensitive hospital marketSkills: Leadership:Marketing & sales I Product launch / Strategy I Financial analysis & forecasting I Portfolio optimization I Hospital Sales Management I Market research I Start-up management I P&L I Business analyticsCoaching & DevelopmentTalent development I Cross functional leadership I Alliance & stakeholder management I Sales operations/Sales effectivenessMarket AccessMarket access & pricing strategy I Government contracts I Hospital contracting I PSP I Trade & distribution strategy I Risk assessmentBusiness DevelopmentBD & licensing I Contract negotiation I BARDA
Listed skills include Oncology, Pharmaceutical Industry, Pharmaceutical Sales, Vaccines, and 42 others.
Current workplace
Sean Mcbride's current company
Company context helps verify the profile and gives searchers a useful next step.
15 roles · 33 years
Sean Mcbride work experience
A career timeline built from the work history available for this profile.
Principal
Cirix Inc.
Healthcare consultancy focused on go to market strategy, tactical optimization, market access, reimbursement & licensing. • For rare disease company, analyze & provide guidance to optimize PLA's & streamline costs utilizing RWE & PSP data.• Researched & developed commercial market & investor strategy for startup medical device company.• Market assessment for US based company evaluating market entry, reimbursement & risks• Life Sciences Ontario (LSO) Advisor, Government Relations & Policy Committee
Advisor, Government Relations & Policy Committee
Organization supporting commercial success for Ontario's life sciences sector through policy change and advocacy.
Vice President Operations, Specialty Health Network
Feb 2024 - Aug 2024
National Director Commercial Operations,
Provide leadership, commercial innovation/ strategy, and executional excellence; for biotech/pharma companies focused in Oncology, Neurology, Inflammation, and Rare Disease. Member Senior Leadership Team. Lead cross functional team of directors creating leading edge patient reimbursement and assistance programs. Oversight includes:- infusion nursing- patient support services (PSP)- reimbursement- advanced data & analytics including RWE and HEOR- PV/QA - Clinical Trial team- SOP and process development, ABAC, ethics and compliance- Public /Private reimbursement-PPN program.- Marketing - Digital innovation - integrating technology to drive superior patient and HCP outcomes.
Apr 2020 - Jan 2024
Vp, Business Development - New Product Commercial Development
Appili Inc.
Private/Venture capital backed startup company with $20M market cap focused only on US & EU markets.• Oversaw BD & new product commercial market access, reimbursement & strategic positioning. Led, coached & developed team, established regional office and corporate processes including implementation of CRM system. • Secured global license for vaccine supporting >50% of company value & an $80M+ FDA incentive. Led market and competitive evaluation, product diligence including HEOR research and full access team assessment, financial modeling and negotiations to deal consummation.• Leveraged public and private market access models to develop unique go to market distribution strategy for rare disease product with accelerated regulatory status. • Forged relations with F500 global partners (Merck, J&J, Pfizer, Roche), government, B2B and supply chain; providing strategic insight, new product opportunities & reduction in supply expenses.• Negotiated & led resource and supply contracts, active pharmaceutical ingredient (API) and contract manufacturing agreements (CMO).
Jul 2017 - Jun 2019
Business Unit Lead - Established Brands Portfolio & Business Development;
Top 10, Global F500 pharmaceutical company with annual revenues of $35B USD, competing in public and private vaccines, & hospital based specialty products including oncology, hematology, respiratory, antivirals and CNS. • Directed business unit with P&L responsibility, led financial and performance targets, generating $176M revenue representing 25% of GSK’s national business. • Revised structure, staffed & coached a high performing team of (4) marketing, business development & (15) cross functional team. Matrix leadership for Medical, Regulatory, Finance, Manufacturing, QA, Legal, Communications/PR, Operations. Led business planning, supply forecasting, & financial management of 40+ asset portfolio including hematology, CNS, Pain, GI, travel & combination drug/device medicines. • Led commercial strategy, analysis & planning including insight driven channel marketing (MCM) & GSK first pilots in digital/DTP campaigns, patient direct reimbursement & private PLA’s which directly added to performance.• Led alignment of 3 yr franchise strategic plans to global vision, managed portfolio budget, optimized supply chain resulting in reduced COGs, business growth (+9%) & adherence metric improvements on priority brands. • Represented Canada on global portfolio team responsible to streamline, restructure & revitalize portfolio profitability. • Developed & negotiated innovative Private Listing Agreement with success of pilot extended to #1 brand.• Led Canadian licensing/divestiture for global GSK transactions and 3rd party contracts including strategic & financial assessment, diligence and negotiation. Recognized by global BD for reducing complexity on specialty care & oncology divestment to Novartis.
Nov 2013 - Jul 2017
Group Manager, Corporate Pricing & Trade Strategy,
• Managed cross functional trade, tender & pricing strategy for ViiV, GSK and Stiefel portfolio, with stakeholders including government, Group Purchasing Organizations, Tumor Site Group leads, HTA groups, and private payers, surpassing objectives despite a highly competitive environment. • Led national execution with provincial government affairs & private payer teams to integrate insights into strategy & ensure market access targets were met. • Monitored & optimized pricing metrics including annual variance, net price performance, analysis of rebates & chargeback’s for contracts, and PMPRB reporting. Reduced rebates year over year.
Feb 2012 - Dec 2013
New Product Marketing – (Haematology/Oncology; Vaccines (Public/Private/Travel)
• Facilitated cross functional strategic launch/business plans for specialty care & hematology/oncology brands, public/private & travel vaccines. Distilled & analyzed complex market, payer, KOL & global team insights into pre-launch strategy. Worked cross functionally to support brand launch, maximize coverage & reimbursement & deliver quality PSP's for 4 & repositioning of 2 oncology brands. • Developed a best in class launch readiness integrating global team, KOL, medical & patient advisory input into the business planning for innovative oncology product. • Leveraged relations forged with Tumor Site Group Leads, reimbursement bodies and patient associations to shape market access, value strategy and budget impact assessment - directly supported formulary listing in two key provinces. • Led analysis of market research data to inform & adjust strategy to maximize oncology / hematology portfolio to plan
May 2007 - Feb 2012
Director
Consulting focused on product & distribution strategy, product assessments, reimbursement, HEOR & market access for launch. Supported pharmaceutical, medical device, diagnostic and Healthcare IT customers. • Led project & client development on strategy & tactical plans for leading Canadian & US healthcare companies including UCB, Nycomed/Altana, Alpha Labs.
2003 - 2007
~4 yrs
Account Director/ Snr. Supervisor
AOR healthcare agency for J&J Pharma, medical device and diagnostic delivering strategy & DTC/DTP (Radio, TV, digital) • Led market research, insight, strategy & message development for first drug eluting stent• Centacor – enhancing PSP (Remicade)• $40M DTC campaign development for neurosurgical shunt• $30M Pilot DTC campaign development for hip & knee replacement • DTC pilot development for point of care diagnostics
2002 - 2003
~1 yr
Director Of Marketing
Global Fortune 500, #2 globally, with annual revenues of $58B USD & hospital products in Cardiology, Oncology, HIV, transplant, CF, Growth Hormone & antivirals• Staffed, coached & led hospital marketing & analytics team for an $85M business unit, P&L responsibility, led 4 cross functional life-cycle teams & managed alliance with Genentech & Roche Diagnostics to outperform objectives.• Led marketing and sales strategy, promotional development, market access and reimbursement programs to drive performance - Gained 98% market share despite a price >10X greater than competitor.• Coached & directed marketing & sales teams to successful launch of new biologics (TNK, tPA Stroke, Cathflo), growth hormone (Nutropin), CF therapy (Pulmozyme - reimbursement), Rituxan & antivirals – Achieved President's award
2000 - 2002
~2 yrs
Hospital & Specialty Business, Sales & Marketing Manager
• Staffed & led business unit including sales (7) & medical support (2). Budgets, business plans, commercial forecast, coaching & performance development - achieving top division & President's Award three out of 4 years.
1997 - 2000
~3 yrs
Hospital & Specialty Business, Marketing Manager (Syntex)
• Brand marketing lead for hospital/specialty brand supporting sales force of 24 reps. Exceeded targets all 4 yrs. • Development of adherence strategy drove patient utilization & delayed brand erosion by 1yr post LOE adding $21M in revenue.• Supported brands in pain management, women's health and obesity.
1994 - 1997
~3 yrs
3 education records
Sean Mcbride education
Bba, Major: Marketing, Finance Minor: Economics
Simon Fraser University
Csc, Securities, Finance
Canadian Securities Institute
Master Of Business Administration - Mba, Strategy/ Digital Marketing
Universidad Isabel I
FAQ
Frequently asked questions about Sean Mcbride
Quick answers generated from the profile data available on this page.
What company does Sean Mcbride work for?
Sean Mcbride works for Life Sciences Ontario.
What is Sean Mcbride's role at Life Sciences Ontario?
Sean Mcbride is listed as Managing Director at Life Sciences Ontario.
What is Sean Mcbride's email address?
AeroLeads has found 1 work email signal at @bayshore.ca for Sean Mcbride at Life Sciences Ontario.
What is Sean Mcbride's phone number?
AeroLeads has found 1 phone signal(s) with area code 902 for Sean Mcbride at Life Sciences Ontario.
Where is Sean Mcbride based?
Sean Mcbride is based in Oakville, Ontario, Canada while working with Life Sciences Ontario.
What companies has Sean Mcbride worked for?
Sean Mcbride has worked for Cirix Inc., Life Sciences Ontario, Lsp Canada - Life Sciences Partnering Canada (Fka Chla), Shoppers Drug Mart Specialty Health Network, and Bayshore Specialty Rx.
How can I contact Sean Mcbride?
You can use AeroLeads to view verified contact signals for Sean Mcbride at Life Sciences Ontario, including work email, phone, and LinkedIn data when available.
What schools did Sean Mcbride attend?
Sean Mcbride holds Bba, Major: Marketing, Finance Minor: Economics from Simon Fraser University.
What skills is Sean Mcbride known for?
Sean Mcbride is listed with skills including Oncology, Pharmaceutical Industry, Pharmaceutical Sales, Vaccines, Medical Devices, Market Access, Healthcare, and Marketing Strategy.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial